Taken together, we identify a pharmacologically targetable PEAK1-INHBA-dependent and SNAI2-associated stromal cell non-autonomous mechanism through which neighboring HER2-positive breast cancer cells increase mitogenic, antiapoptotic and stress signaling activity; acquire lapatinib resistance; and metastasize to the brain (Fig. 8t). The gene discussed is PEAK1; the disease is breast cancer.